U.S. FDA
134
© Siemens AG 2003, E:\Auftrag\Siemens
\MobilePhones\FCCs\sl75\FUG\am_FDA.FM
left page (134)
of SL75 Hydra FUG, w/o ptt, us-en, A31008-H3300-A1-1-7619 (06.10.2005, 15:10)
Template: X75, Version 2.2;VAR La
nguage:
am; VAR issue date: 050822
• World Health Organization (WHO)
International Commission on
Non-Ionizing Radiation Protection
(select Qs & As):
• United Kingdom, National Radio-
logical Protection Board:
• Cellular Telecommunications In-
dustry Association (CTIA):
• U.S. Food and Drug Administra-
tion (FDA) Center for devices and
Radiological Health:
http://www.fda.gov/cdhr/consumer/
1
Muscat et al. Epidemiological Study of Cel-
lular Telephone Use and Malignant Brain
Tumors. In: State of the Science Symposi-
um; 1999 June 20; Long Beach, California.
2
Tice et al. Tests of mobile phone signals for
activity in genotoxicity and other laboratory
assays. In: Annual Meeting of the Environ-
mental Mutagen Society; March 29, 1999,
Washington, DC; and personal communica-
tion, unpublished results.
3
Preece, AW, Iwi, G, Davies-Smith, A,
Wesnes, K, Butler, S, Lim, E, and Varey, A.
Effect of a 915- MHz simulated mobile
phone signal on cognitive function in man.
Int. J. Radiat. Biol., April 8, 1999.
4
Hardell, L, Nasman, A, Pahlson, A, Hal-
lquist, A and Mild, KH. Use of cellular tele-
phones and the risk for brain tumors; a case-
control study. Int. J. Oncol, 15: 113-116,
1999.